These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38670431)

  • 41. Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD).
    Slater BJ; Collings A; Dirks R; Gould JC; Qureshi AP; Juza R; Rodríguez-Luna MR; Wunker C; Kohn GP; Kothari S; Carslon E; Worrell S; Abou-Setta AM; Ansari MT; Athanasiadis DI; Daly S; Dimou F; Haskins IN; Hong J; Krishnan K; Lidor A; Litle V; Low D; Petrick A; Soriano IS; Thosani N; Tyberg A; Velanovich V; Vilallonga R; Marks JM
    Surg Endosc; 2023 Feb; 37(2):781-806. PubMed ID: 36529851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is patient satisfaction sufficient to validate endoscopic anti-reflux treatments?
    Bortolotti M
    World J Gastroenterol; 2022 Jul; 28(28):3743-3746. PubMed ID: 36161053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
    Kalapala R; Singla N; Reddy DN
    Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency.
    Liang WT; Wu JM; Hu ZW; Wang ZG; Zhu GC; Zhang C
    Minerva Chir; 2014 Jun; 69(3):121-7. PubMed ID: 24970301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease.
    Funk LM; Zhang JY; Drosdeck JM; Melvin WS; Walker JP; Perry KA
    Surgery; 2015 Jan; 157(1):126-36. PubMed ID: 25262216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Current aspects of surgical treatment of gastro-esophageal reflux disease].
    Danilova DA; Bazaev AV; Gorbunova LI
    Khirurgiia (Mosk); 2020; (2):89-94. PubMed ID: 32105262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is transoral incisionless fundoplication (TIF) an answer to post-peroral endoscopic myotomy gastroesophageal reflux? A multicenter retrospective study.
    Brewer Gutierrez OI; Chang KJ; Benias PC; Sedarat A; Dbouk MH; Godoy Brewer G; Lee DP; Okolo Iii PI; Canto MI; Khashab MA
    Endoscopy; 2022 Mar; 54(3):305-309. PubMed ID: 34049409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication.
    Perry KA; Linn JG; Eakin JL; Onders RP; Velanovich V; Melvin WS
    J Laparoendosc Adv Surg Tech A; 2013 May; 23(5):456-8. PubMed ID: 23578416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastroesophageal reflux disease: When East meets West.
    Xiao YL
    J Dig Dis; 2022 Apr; 23(4):192-195. PubMed ID: 35195924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication.
    Huynh P; Konda V; Sanguansataya S; Ward MA; Leeds SG
    Surg Laparosc Endosc Percutan Tech; 2020 Dec; 31(2):264-276. PubMed ID: 33347088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.
    Cadière GB; Van Sante N; Graves JE; Gawlicka AK; Rajan A
    Surg Endosc; 2009 May; 23(5):957-64. PubMed ID: 19288158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic full-thickness plication along with argon plasma coagulation for treatment of proton pump inhibitor dependent gastroesophageal reflux disease.
    Harwani Y; Butala S; More B; Shukla V; Patel A
    World J Gastrointest Endosc; 2024 May; 16(5):250-258. PubMed ID: 38813575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transoral incisionless fundoplication with or without hiatal hernia repair for gastroesophageal reflux disease after peroral endoscopic myotomy.
    DeWitt JM; Al-Haddad M; Stainko S; Perkins A; Fatima H; Ceppa DP; Birdas TJ
    Endosc Int Open; 2024 Jan; 12(1):E43-E49. PubMed ID: 38188922
    [No Abstract]   [Full Text] [Related]  

  • 58. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease.
    Aziz AM; El-Khayat HR; Sadek A; Mattar SG; McNulty G; Kongkam P; Guda MF; Lehman GA
    Surg Endosc; 2010 Apr; 24(4):818-25. PubMed ID: 19730952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of a transluminal endoscopic fundoplication for the treatment of pediatric gastroesophageal reflux disease.
    Chen S; Jarboe MD; Teitelbaum DH
    Pediatr Surg Int; 2012 Mar; 28(3):229-34. PubMed ID: 22124618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication.
    Bell RC; Fox MA; Barnes WE; Mavrelis PG; Sewell RW; Carter BJ; Ihde GM; Trad KS; Dargis D; Hoddinott KM; Freeman KD; Gunsberger T; Hausmann MG; Gill BD; Wilson E
    Surg Endosc; 2014 Oct; 28(10):2949-58. PubMed ID: 24879134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.